These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production. Wiranowska-Stewart M; Hadden JW Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734 [TBL] [Abstract][Full Text] [Related]
5. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762 [TBL] [Abstract][Full Text] [Related]
6. Effect of lead, polychlorinated biphenyls, and cyclophosphamide on rat natural killer cells, interleukin 2, and antibody synthesis. Exon JH; Talcott PA; Koller LD Fundam Appl Toxicol; 1985 Feb; 5(1):158-64. PubMed ID: 3921421 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function. Ikehara S; Hadden JW; Good RA; Lunzer DG; Pahwa RN Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135 [TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide-conditioned suppression of the natural killer cell response in rats. O'Reilly CA; Exon JH Physiol Behav; 1986; 37(5):759-64. PubMed ID: 3490676 [TBL] [Abstract][Full Text] [Related]
9. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109 [TBL] [Abstract][Full Text] [Related]
10. Isoprinosine and NPT 15392: immunomodulation and cancer. Simon LN; Hoehler FK; McKenzie DT; Hadden JW Adv Exp Med Biol; 1983; 166():241-59. PubMed ID: 6196956 [TBL] [Abstract][Full Text] [Related]
11. Effects of isoprinosine in animal models of depressed T-cell function. Binderup L Int J Immunopharmacol; 1985; 7(1):93-101. PubMed ID: 2581907 [TBL] [Abstract][Full Text] [Related]
12. Isoprinosine as an immunopotentiator. Renoux G; Renoux M; Guillaumin JM J Immunopharmacol; 1979; 1(3):337-56. PubMed ID: 95412 [TBL] [Abstract][Full Text] [Related]
13. The effects of methylnitrosourea (MNU) on natural killer (NK) cell cytotoxicity and cytokine production in rats. Talcott PA; Exon JH; Koller LD Carcinogenesis; 1990 May; 11(5):829-34. PubMed ID: 2185903 [TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic exposure of rats to 2-methoxyethanol or 2-butoxyethanol: thymic atrophy and immunotoxicity. Exon JH; Mather GG; Bussiere JL; Olson DP; Talcott PA Fundam Appl Toxicol; 1991 May; 16(4):830-40. PubMed ID: 1715831 [TBL] [Abstract][Full Text] [Related]
15. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro. Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K Nephron; 1987; 46(3):243-6. PubMed ID: 2442634 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of immune function in mice exposed to Ordram. Smialowicz RJ; Luebke RW; Rogers RR; Riddle MM; Rowe DG Toxicology; 1985 Dec; 37(3-4):307-14. PubMed ID: 3878015 [TBL] [Abstract][Full Text] [Related]
17. Hypophysectomy and growth hormone replacement effects on multiple immune responses in rats. Exon JH; Bussiere JL; Williams JR Brain Behav Immun; 1990 Jun; 4(2):118-28. PubMed ID: 2393723 [TBL] [Abstract][Full Text] [Related]
18. Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392. O'Neill BB; Ginsberg T; Hadden J Prog Clin Biol Res; 1984; 161():525-41. PubMed ID: 6207547 [No Abstract] [Full Text] [Related]
19. Effect of CI-949 and CI-959 on immune function and lymphoid organs in rats. Koller LD; Voller BE; Hedstrom OR; Steppan LG; Kerkvliet NI; Thueson DO Int J Immunopharmacol; 1989; 11(5):509-16. PubMed ID: 2807627 [TBL] [Abstract][Full Text] [Related]
20. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions. Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]